Microplastics (MPs), defined as plastic particles smaller than 5 mm, have emerged as a global environmental and public health crisis, infiltrating air, water, soil, and food systems worldwide. MPs originate from the breakdown of larger plastic debris, single-use plastics, and industrial processes, entering food. Emerging evidence underscores the ability of MPs to cross biological barriers, including the blood–brain barrier, triggering neuroinflammatory responses and contributing to neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Polystyrene (PS), a common type of MP, activates microglial cells, releasing pro-inflammatory cytokines like tumor necrosis factor (TNF-α) and interleukins, which increase neuronal damage. MPs have also been linked to cardiovascular diseases, with studies detecting polyethylene (PE) and polyvinyl chloride (PVC) in carotid artery plaques, increasing the risk of myocardial infarction and stroke. Furthermore, MPs disrupt endocrine function, alter lipid metabolism, and induce gut microbiome imbalances, posing multifaceted health risks. In the MENA region, MP pollution is particularly severe, with the Mediterranean Sea receiving an estimated 570,000 tons of plastic annually, equivalent to 33,800 plastic bottles per minute. Studies in Egypt, Lebanon, and Tunisia document high MP concentrations in marine ecosystems, with herbivorous fish like Siganus rivulatus containing over 1000 MPs per individual due to the ingestion of contaminated seaweed. Despite these findings, public awareness and regulatory frameworks remain inadequate, with only 24% of Egyptians demonstrating sufficient knowledge of safe plastic use. This review emphasizes the urgent need for region-specific research, policy interventions, and public awareness campaigns to address MP pollution. Recommendations include sustainable waste management practices, the promotion of biodegradable alternatives, and enhanced monitoring systems to mitigate the health and environmental impacts of MPs in the MENA region.

Pharmacogenomics (PGx) is the hope for the full optimization of drug therapy while minimizing the accompanying adverse drug events that cost billions of dollars annually. Since years before the century, it has been known that inter-individual variations contribute to differences in specific drug responses. It is the bridge to what is well-known today as “personalized medicine”. Addressing the drug’s pharmacokinetics and pharmacodynamics is one of the features of this science, owing to patient characteristics that vary on so many occasions. Mainly in the liver parenchymal cells, intricate interactions between the drug molecules and enzymes family of so-called “Cytochrome P450” occur which hugely affects how the body will react to the drug in terms of metabolism, efficacy, and safety. Single nucleotide polymorphisms, once validated for a transparent and credible clinical utility, can be used to guide and ensure the succession of the pharmacotherapy plan. Novel tools of pharmacoeconomics science are utilized extensively to assess cost-effective pharmacogenes preceding the translation to the bedside. Drug development and discovery incorporate a drug-gene perspective and save more resources. Regulations and laws shaping the clinical PGx practice can be misconceived; however, these pre-/post approval processes ensure the product’s safety and efficacy. National and international regulatory agencies seek guidance on maintaining conduct in PGx practice. In this patient-centric era, social and legal considerations manifest in a way that makes them unavoidable, involving patients and other stakeholders in a deliberate journey toward utmost patient well-being. In this comprehensive review, we contemporarily addressed the scientific leaps in PGx, along with various challenges that face the proper implementation of personalized medicine in Egypt. These informative insights were drawn to serve what the Egyptian population, in particular, would benefit from in terms of knowledge and know-how while maintaining the latest global trends. Moreover, this review is the first to discuss various modalities and challenges faced in Egypt regarding PGx, which we believe could be used as a pilot piece of literature for future studies locally, regionally, and internationally.